332 related articles for article (PubMed ID: 6455174)
1. Effects of acute administration of ethane hydroxydiphosphonate (EHDP) on skeletal scintigraphy with technetium-99m methylene diphosphonic acid (Tc-MDP) in the rat.
Watt I; Hill P
Br J Radiol; 1981 Jul; 54(643):592-6. PubMed ID: 6455174
[TBL] [Abstract][Full Text] [Related]
2. Bone-seeking properties of Tc-99m carbonyl diphosphonic acid, dihydroxy-methylene diphosphonic acid and monohydroxy-methylene phosphoinic acid: concise communication.
Wang TS; Fawwaz RA; Johnson LJ; Mojdehi GE; Johnson PM
J Nucl Med; 1980 Aug; 21(8):767-70. PubMed ID: 7400832
[TBL] [Abstract][Full Text] [Related]
3. Biokinetics of bone tracers by means of deconvolution analysis--comparison of 99mTc MDP, 99mTc DPD and 99mTc EHDP.
Knop J; Stritzke P; Kröger E; Schneider C; Wasmus G
Nuklearmedizin; 1982 Aug; 21(4):145-9. PubMed ID: 6216459
[TBL] [Abstract][Full Text] [Related]
4. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. II. Comparison of Tc-99m hydroxymethylene diphosphonate (HMDP) with other technetium-labeled bone-imaging agents in a canine model.
Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
J Nucl Med; 1980 Oct; 21(10):967-70. PubMed ID: 6252299
[TBL] [Abstract][Full Text] [Related]
5. A study of the relationship between chemical structure and bone localization of Tc-99m diphosphonic acids: concise communication.
Wang TS; Mojdehi GE; Fawwaz RA; Johnson PM
J Nucl Med; 1979 Oct; 20(10):1066-70. PubMed ID: 536757
[TBL] [Abstract][Full Text] [Related]
6. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. I. Synthesis and distribution in animals.
Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
J Nucl Med; 1980 Oct; 21(10):961-6. PubMed ID: 6252298
[TBL] [Abstract][Full Text] [Related]
7. A comparison of skeletal uptakes of three diphosphonates by whole-body retention: concise communication.
Fogelman I; Pearson DW; Bessent RG; Tofe AJ; Francis MD
J Nucl Med; 1981 Oct; 22(10):880-3. PubMed ID: 6457135
[TBL] [Abstract][Full Text] [Related]
8. Duration of etidronate effect demonstrated by serial bone scintigraphy.
Sandler ED; Parisi MT; Hattner RS
J Nucl Med; 1991 Sep; 32(9):1782-4. PubMed ID: 1908891
[TBL] [Abstract][Full Text] [Related]
9. Computer analysis of Tc-99m DPD and Tc-99m MDP kinetics in humans: concise communication.
Mele M; Conte E; Fratello A; Pasculli D; Pieralice M; D'Addabbo A
J Nucl Med; 1983 Apr; 24(4):334-8. PubMed ID: 6834136
[TBL] [Abstract][Full Text] [Related]
10. Technetium-99m-methylene diphosphonate--a superior agent for skeletal imaging: comparison with other technetium complexes.
Subramanian G; McAfee JG; Blair RJ; Kallfelz FA; Thomas FD
J Nucl Med; 1975 Aug; 16(8):744-55. PubMed ID: 170385
[TBL] [Abstract][Full Text] [Related]
11. Comparative evaluation of three diphosphonates: in vitro adsorption (C- 14 labeled) and in vivo osteogenic uptake (Tc-99m complexed).
Francis MD; Ferguson DL; Tofe AJ; Bevan JA; Michaels SE
J Nucl Med; 1980 Dec; 21(12):1185-9. PubMed ID: 6449567
[TBL] [Abstract][Full Text] [Related]
12. New diphosphonate compounds for skeletal imaging: comparison with methylene diphosphonate.
Subramanian G; McAfee JG; Thomas FD; Feld TA; Zapf-Longo C; Palladino E
Radiology; 1983 Dec; 149(3):823-8. PubMed ID: 6316414
[TBL] [Abstract][Full Text] [Related]
13. Tc-99m hydroxymethylene diphosphonate and Tc-99m methylene diphosphonate: biological and clinical comparison: concise communication.
Littlefield JL; Rudd TG
J Nucl Med; 1983 Jun; 24(6):463-6. PubMed ID: 6222166
[TBL] [Abstract][Full Text] [Related]
14. Chromium 51 EDTA/technetium 99m MDP plasma ratio to measure total skeletal function.
Nisbet AP; Edwards S; Lazarus CR; Malamitsi J; Maisey MN; Mashiter GD; Winn PJ
Br J Radiol; 1984 Aug; 57(680):677-80. PubMed ID: 6235885
[TBL] [Abstract][Full Text] [Related]
15. [Clinical observation of diffuse renal accumulation of 99mTc-MDP].
Takeji H; Sui O; Shimazu H; Watanabe N; Kawaguchi K; Kawahara Y; Komatsu Y; Yoshida S
Rinsho Hoshasen; 1984 Aug; 29(8):875-9. PubMed ID: 6210380
[No Abstract] [Full Text] [Related]
16. Differential skeletal uptake of Tc-99m-tagged pyrophosphate and methylene diphosphonate in leukemia.
Armas R; Neumann R; Goldsmith SJ
J Nucl Med; 1983 Sep; 24(9):799-802. PubMed ID: 6310070
[TBL] [Abstract][Full Text] [Related]
17. [Uptake of 99mTc-MDP by the lung and liver].
Ohchida T; Ichiya A; Matsuura K; Ooiwa T
Rinsho Hoshasen; 1984 Mar; 29(3):437-8. PubMed ID: 6235386
[No Abstract] [Full Text] [Related]
18. [Quantitative whole-body bone scintigraphy. II. Pharmacokinetics of osteotropic radiopharmaceuticals (author's transl)].
Anger K; Aigner S; Bühler M; Umbach I
Nuklearmedizin; 1980 Jul; 19(3):97-107. PubMed ID: 7465432
[TBL] [Abstract][Full Text] [Related]
19. [Comparison of the usefulness of Technetium 99m-labeled ethylidene-1-hydroxy-1,1'-diphosphonic acid (EHDP) and methylene diphosphonic acid (MDP) of Polish production for the diagnosis of bone metastases in patients treated at the Oncology Center, Institute of Oncology in Warsaw 1979-1987].
Kozłowicz-Gudzińska I; Rysińska A; Giwojno A
Nowotwory; 1988; 38(3):161-4. PubMed ID: 3149728
[No Abstract] [Full Text] [Related]
20. Tc-99m MDP and indium-111 chloride scintigraphy in skeletal tuberculosis.
Nocera RM; Sayle B; Rogers C; Wilkey D
Clin Nucl Med; 1983 Sep; 8(9):418-20. PubMed ID: 6227442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]